Insider trading

Period: 120 months Stock: VRTX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

737 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

737 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

737 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

737 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
737 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
737 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

737 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
6 Feb 2020
Parini Michael EVP, CL&AO
Sold, plan not stated 4×
$604.78K 2,526 at 239.42
3.6%
6 Feb 2020
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 4×
$604.77K 2,526 at 239.42
3.5%
6 Feb 2020
Kewalramani Reshma EVP and CMO
Sold, plan not stated 4×
$496.60K 2,074 at 239.44
5.6%
6 Feb 2020
Lee Yuchun Director
Sold, plan not stated 4×
$479.02K 2,000 at 239.51
51.6%
Sold half or more
6 Feb 2020
Tatsis Ourania SVP, CRO
Sold, plan not stated 4×
$231.53K 967 at 239.43
5.4%
6 Feb 2020
Silva Paul M SVP & Controller
Sold, plan not stated 3×
$111.52K 466 at 239.32
1.5%
5 Feb 2020
Lee Yuchun Director
Sold, plan not stated 4×
$484.76K 2,000 at 242.38
51.6%
Sold half or more
4 Feb 2020
Lee Yuchun Director
Sold, plan not stated 6×
$477.67K 2,000 at 238.84
51.6%
Sold half or more
3 Feb 2020
Parini Michael EVP, CL&AO
Sold, plan not stated 5×
$1.03M 4,436 at 231.14
12.3%
3 Feb 2020
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 4×
$953.86K 4,126 at 231.18
11.6%
3 Feb 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated 5×
$946.85K 4,097 at 231.11
10.2%
3 Feb 2020
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated 5×
$857.47K 3,710 at 231.12
10.0%
3 Feb 2020
Silva Paul M SVP & Controller
Sold, plan not stated 5×
$484.94K 2,099 at 231.03
10.6%
3 Feb 2020
Lee Yuchun Director
Sold, plan not stated 4×
$462.20K 2,000 at 231.10
70.2%
Sold half or more
31 Jan 2020
SACHS BRUCE I Director
Sold, plan not stated 12×
$4.56M 20,000 at 227.99
64.1%
Sold half or more
31 Jan 2020
Arbuckle Stuart A EVP, Chief Commercial Officer
Sold, plan not stated
$1.12M 4,692 at 238.65
12.4%
31 Jan 2020
Parini Michael EVP, CL&AO
Sold, plan not stated
$932.88K 3,909 at 238.65
10.0%
31 Jan 2020
Lee Yuchun Director
Sold, plan not stated 7×
$456.04K 2,000 at 228.02
41.3%
31 Jan 2020
Silva Paul M SVP & Controller
Sold, plan not stated
$333.16K 1,396 at 238.65
7.3%
22 Jan 2020
Parini Michael EVP, CL&AO
Sold, plan not stated
$237.50 1 at 237.50
0.0%
16 Jan 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated
$1.18M 5,000 at 235.00
12.1%
13 Jan 2020
Parini Michael EVP, CL&AO
Sold, plan not stated 4×
$481.91K 2,125 at 226.78
5.7%
13 Jan 2020
Silva Paul M SVP & Controller
Sold, plan not stated
$197.27K 860 at 229.38
4.6%
8 Jan 2020
Silva Paul M SVP & Controller
Sold, plan not stated
$3.19M 13,750 at 231.89
43.6%
8 Jan 2020
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated
$1.15M 5,000 at 230.00
12.1%
8 Jan 2020
Tatsis Ourania SVP, CRO
Sold, plan not stated
$381.11K 1,675 at 227.53
18.8%
6 Jan 2020
Parini Michael EVP, CL&AO
Sold, plan not stated 6×
$943.51K 4,250 at 222.00
10.8%
2 Jan 2020
Silva Paul M SVP & Controller
Sold, plan not stated 4×
$5.61M 25,630 at 218.92
59.1%
Sold half or more
2 Jan 2020
YOUNG WILLIAM D Director
Sold, plan not stated 4×
$4.38M 20,000 at 218.93
68.2%
Sold half or more
30 Dec 2019
YOUNG WILLIAM D Director
Sold, plan not stated 4×
$6.56M 30,000 at 218.76
76.3%
Sold half or more
9 Dec 2019
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated
$1.13M 5,000 at 225.00
13.0%
25 Nov 2019
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated
$1.10M 5,000 at 220.00
13.0%
25 Nov 2019
Kewalramani Reshma EVP and CMO
Sold, plan not stated
$1.03M 4,692 at 219.37
26.4%
25 Nov 2019
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated
$857.74K 3,910 at 219.37
11.0%
19 Nov 2019
LEIDEN JEFFREY M CEO & President
Sold, plan not stated 3×
$20.36M 96,534 at 210.91
47.6%
19 Nov 2019
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated
$1.08M 5,000 at 215.00
13.0%
18 Nov 2019
LEIDEN JEFFREY M CEO & President
Sold, plan not stated 2×
$931.14K 4,434 at 210.00
4.0%
15 Nov 2019
LEIDEN JEFFREY M CEO & President
Sold, plan not stated 2×
$1.05M 5,000 at 210.00
4.5%
15 Nov 2019
Parini Michael EVP, CL&AO
Sold, plan not stated
$17.30K 84 at 205.95
0.2%
15 Nov 2019
Kewalramani Reshma EVP and CMO
Sold, plan not stated
$12.56K 61 at 205.95
0.5%
15 Nov 2019
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated
$12.36K 60 at 205.95
0.2%
15 Nov 2019
Sachdev Amit EVP, Chief Patient Officer
Sold, plan not stated
$11.74K 57 at 205.95
0.2%
15 Nov 2019
Arbuckle Stuart A EVP\Chief Commercial Officer
Sold, plan not stated
$3.91K 19 at 205.95
0.1%
15 Nov 2019
Tatsis Ourania SVP, CRO
Sold, plan not stated
$1.03K 5 at 205.95
0.1%
13 Nov 2019
Arbuckle Stuart A EVP\Chief Commercial Officer
Sold, plan not stated
$1.76M 8,560 at 205.57
20.5%
13 Nov 2019
Parini Michael EVP, CL&AO
Sold, plan not stated
$1.01M 4,892 at 205.50
12.3%
13 Nov 2019
Tatsis Ourania SVP, CRO
Sold, plan not stated
$586.55K 2,853 at 205.59
28.2%
8 Nov 2019
Kewalramani Reshma EVP and CMO
Sold, plan not stated
$101.29K 509 at 199.00
3.7%
6 Nov 2019
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 3×
$241.19K 1,223 at 197.21
3.7%
4 Nov 2019
ALTSHULER DAVID EVP, Global Research and CSO
Sold, plan not stated 2×
$827.05K 4,126 at 200.45
11.6%
Showing 401–450 of 737. ← Newer Page 9 of 15 Older →